Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
FLY LDN is a fitness brand that imparts sports and fitness instruction via its digital platform and its studios in central London and Fitzrovia. The company launched its video-on-demand and live-streaming fitness platform, FLY LDN Online (FLO), in September 2020. It asserts that within six months of launch, FLO scaled over 28,000 monthly views across 80+ countries with users having viewed over 2.5 million minutes of FLY LDN workouts. FLY LDN won the Men's Health 'Best Studio 2019' award and was commended at the 2018 and 2019 Tatler Gym Awards. The company has also received press coverage in publications like Women's Health, Forbes, Esquire, Elle, Vogue, GQ and Glamour. It has also partnered with brands such as DKNY and ASOS. FLY LDN aspires to become a contender in the global online fitness market that is expected to reach $59 billion by 2027. The company will use the investment to further develop additional functionality and TV apps for FLO and fund marketing campaigns to fuel growth.
days to go:
Expired
investment:
£340,928
Total Be wants to bring an internationally recognised model of car insurance to the UK. It provides insurance for the car, not just for an individual driver. Additionally, it does not take crime data into account that is not specific to vehicles. Thus, this insurance is estimated to provide up to 25% cheaper cover in comparison to UK insurance. Moreover, a UK Government Petition for this insurance model has gained over 60,000+ signatures, which further validates the demand of this model. Total Be believes that it will be able to disrupt the UK market with this car insurance model.
days to go:
Expired
investment:
£150,760
Spendology is a fintech company that licenses a digital-first SaaS-based travel money platform to retailers globally, addressing the demand for travel cash, which remains popular among Brits, with over £56 billion spent annually. Inspired by the inconvenience of traditional currency exchange services, the company's chairman, Don Clark, aims to revolutionize the industry, much like he did in a previous financial services venture that resulted in a significant sale. Spendology's innovative platform allows travel companies to offer online ordering and home delivery of travel cash, generating additional profits for these businesses and royalties for Spendology. Their platform is available to travel companies of all sizes worldwide, already operating in the UK and launching in the US, with plans to expand to 28 countries, serving a market worth $1 trillion.
days to go:
Expired
investment:
£354,053
Skinny Tonic™ is the first Zero Calorie, Nothing Artificial, and Zero Sugar, 100 % Natural Tonic Water in the UK. It has a nationwide listing in Asda and a 2nd major listing agreed for 2020. Skinny Tonic™ also has been listed in major retailers including Amazon and Costco. The company has a bespoke, fully automated production facility capable of producing 6,000 cans per hour. With the proceeds, the company will recruit a marketing and sales team. Additionally, Skinny Tonic™ will increase its product development and production capacity.
days to go:
Expired
investment:
£1,783,994
Website: www.riskrewardlimited.com
Risk Reward Ltd is a global banking and financial services training, consultancy and recruitment specialist that operates from its offices in London and recently opened a second office in Miami to service its business in the Americas. The company specialises in risk and compliance training and recruitment, the fastest growing part of the sector.
The business is raising equity investment for the first time in its 13-year history, giving investors the first opportunity to become part of this successful and fast growing business.
Established in 2002, Risk Reward’s client list has evolved to incorporate the names of national and international banks, leading financial services companies and insurance firms spanning five continents. Clients include international training firms and specific banks including the British Bankers Association, GPS, MIS, Al Rajhi Bank, FBN, First Gulf Bank, HSBC, Lloyds Bank, Wells Fargo and many more prominent names.
Several growth-spurring developments are happening simultaneously to lead the company to offer 5% in its market-leading business to new investors:
* Exceptional growth in its training business; the company has developed its retail training business in London and Dubai, and has also developed its multi-lingual global training services
* Investment has been made in development of a new recruitment businesses which is now approved by a number of companies and has been followed by taking over the business of Buckley Alan, a 12 year old recruitment firm
* Recently opened a US office in Miami
* Developed a learning management system which is successfully installed in a major bank and links skills to training delivery
* Published two best-selling money laundering deterrence works and a major text on business mathematics
* Approved by 5 major institutes to offer their training products including the CISI, ICAEW and ACAMS
Sales vary month on month between £150,000 and £200,000, and recent unsolicited valuations have put the company’s worth between £7-12 million.
These valuations also took into account the level of investment written off during the year developing the learning management system, recruitment business and US office. Business growth is around 25% per annum in this fast growing sector.
The fast-moving business requires equity investment to fuel its growth as the company strives to develop its already-strong position as a technical leader in its space.
This pitch represents an opportunity to invest in a respected training and recruitment business with a wealth of prominent clients.
days to go:
Expired
investment:
£25,300
